Mariner’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136K | Sell |
14,507
-2,046
| -12% | -$19.2K | ﹤0.01% | 3175 |
|
|
2025
Q1 | $118K | Buy |
16,553
+1,733
| +12% | +$12.3K | ﹤0.01% | 3150 |
|
|
2024
Q4 | $173K | Sell |
14,820
-2,496
| -14% | -$29.1K | ﹤0.01% | 3056 |
|
|
2024
Q3 | $357K | Buy |
17,316
+1,822
| +12% | +$37.5K | ﹤0.01% | 2422 |
|
|
2024
Q2 | $347K | Sell |
15,494
-1,779
| -10% | -$39.8K | ﹤0.01% | 2340 |
|
|
2024
Q1 | $475K | Buy |
17,273
+466
| +3% | +$12.8K | ﹤0.01% | 2064 |
|
|
2023
Q4 | $512K | Buy |
16,807
+2,610
| +18% | +$79.6K | ﹤0.01% | 1917 |
|
|
2023
Q3 | $449K | Buy |
14,197
+160
| +1% | +$5.06K | ﹤0.01% | 1853 |
|
|
2023
Q2 | $572K | Buy |
14,037
+165
| +1% | +$6.73K | ﹤0.01% | 1650 |
|
|
2023
Q1 | $516K | Buy |
13,872
+697
| +5% | +$25.9K | ﹤0.01% | 1670 |
|
|
2022
Q4 | $460K | Sell |
13,175
-364
| -3% | -$12.7K | ﹤0.01% | 1702 |
|
|
2022
Q3 | $758K | Sell |
13,539
-3,721
| -22% | -$208K | ﹤0.01% | 1194 |
|
|
2022
Q2 | $894K | Buy |
17,260
+1,034
| +6% | +$53.6K | ﹤0.01% | 938 |
|
|
2022
Q1 | $1.18M | Buy |
16,226
+1,195
| +8% | +$86.8K | ﹤0.01% | 883 |
|
|
2021
Q4 | $1.78M | Buy |
15,031
+84
| +0.6% | +$9.93K | 0.01% | 684 |
|
|
2021
Q3 | $2.01M | Sell |
14,947
-38
| -0.3% | -$5.1K | 0.01% | 538 |
|
|
2021
Q2 | $2.43M | Buy |
+14,985
| New | +$2.43M | 0.02% | 453 |
|